Broad market headline — check whether risk appetite shifts.
Watch: .SPX · .FTSE · .N225 · @CL.1
← Markets · United States hub · Watchlists · Compare · News
VRTX
Vertex Pharmaceuticals is a healthcare name tracked on StockWatch with delayed quotes, charts, and related news. Home market: United States.
Sign in to jump from your saved watchlists.
$479.00
+1.64+0.34%
CNBCJul 27, 2026, 8:00 PM
Delayed market data from CNBC. Not investment advice.
About Vertex Pharmaceuticals
HealthcareUnited States · United States market hub
Vertex Pharmaceuticals is a healthcare name tracked on StockWatch with delayed quotes, charts, and related news. Home market: United States.
Key statistics
Delayed fundamentals for VRTX · Finnhub.
- Market cap
- $123.10B
- P/E (TTM)
- 31.14
- EPS (TTM)
- $16.8667
- Div. yield
- —
- 52-week range
- $362.50 – $533.67
- Volume
- —
- Avg volume
- 1.24M
Price history
OHLC candles for VRTX · 3mo · 1day · Twelve Data · EMA / RSI
News for VRTX
See all newsDirect mentions, stories that impact this name, and related market themes — with Impact Analysis on each headline.
- Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?
- Vertex Pharmaceuticals (VRTX) Projected to Announce Quarterly Earnings on Monday
- Sei Investments Co. Sells 230,797 Shares of Vertex Pharmaceuticals Incorporated $VRTX
- Vertex Pharmaceuticals Incorporated $VRTX Position Reduced by Cetera Investment Advisers
- Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Renaissance Technologies LLC
- Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by PNC Financial Services Group Inc.
- Arrowstreet Capital Limited Partnership Acquires 45,003 Shares of Vertex Pharmaceuticals Incorporated $VRTX